|
Volumn 22, Issue 3, 2003, Pages 631-637
|
Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
GROWTH PROMOTOR;
INTERLEUKIN 6;
MONOCLONAL ANTIBODY;
RECOMBINANT PROTEIN;
ADULT;
APOPTOSIS;
ARTICLE;
BONE MARROW CELL;
CASE REPORT;
CELL DIVISION;
COCULTURE;
DRUG ANTAGONISM;
DRUG EFFECT;
EXON;
FATALITY;
GENETICS;
HUMAN;
IMMUNOLOGY;
IMMUNOPHENOTYPING;
ISOLATION AND PURIFICATION;
MALE;
METABOLISM;
MULTIPLE MYELOMA;
ONCOGENE MYC;
PATHOLOGY;
PHYSIOLOGY;
POLYMERASE CHAIN REACTION;
SINGLE STRAND CONFORMATION POLYMORPHISM;
STROMA CELL;
TUMOR CELL LINE;
TUMOR SUPPRESSOR GENE;
ADULT;
ANTIBODIES, MONOCLONAL;
APOPTOSIS;
BIOLOGICAL FACTORS;
BONE MARROW CELLS;
CELL DIVISION;
CELL LINE, TUMOR;
COCULTURE TECHNIQUES;
EXONS;
FATAL OUTCOME;
GENES, MYC;
GENES, P53;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
GROWTH SUBSTANCES;
HUMANS;
IMMUNOPHENOTYPING;
INTERLEUKIN-6;
MALE;
MULTIPLE MYELOMA;
POLYMERASE CHAIN REACTION;
POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;
RECOMBINANT PROTEINS;
STROMAL CELLS;
|
EID: 0642287625
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|